The melanocortin system consists of four melanocortin peptides (α-, β-, γ-MSH, and ACTH) that are derived from the proopiomelanocortin gene, five melanocortin receptors (MC1R-MC5R), two endogenous antagonists (agouti and agouti-related protein [AGRP]), and two ancillary proteins (mahogany and syndecan-3). Melanocortin participates in diverse physiological functions that include energy homeostasis. By playing a central role in feeding behavior, melanocortin regulates obesity. 1 Leptin, an adipose-derived hormone, uses melanocortin as an effector system to regulate energy balance. 2 Signal transducers and activators of transcription-3 (STAT3) via the mitogen-activated protein kinase (MAPK) pathway 3 has been proposed to affect signaling between leptin and melanocortin. Leptin reduces body weight gain, 4 and its levels are substantially elevated in obese individuals. 5 Though the ability of leptin to reduce body weight is restricted upon development of leptin resistance, its ability to increase sympathetic nerve activity (SNA) is retained. A study conducted to determine interaction of the leptin and melanocortin system with SNA in anesthetized Sprague-Dawley rats suggests that leptin increases renal SNA through activation of hypothalamic melanocortin receptors. 6 An increase in SNA is believed to have the ability to increase blood pressure in obese individuals, 7 and such an ability has been demonstrated in a Zucker rat model. 8 Activation or deactivation of MC3R/MC4R has been demonstrated to modulate SNA levels. 8 Central administration of an MC3R/4R antagonist SHU9119 in genetically obese KKA y mice demonstrates elevated blood pressure with increased plasma leptin levels and urinary catecholamine excretion. 9 Similarly, targeted disruption of the MC3R gene with a high-sodium diet leads to hypertension and elevated levels of ϒ-MSH in plasma. 10,11 Studies of MC4R-deficient individuals of European descent have implicated melanocortinergic signaling in the control of human blood pressure through an insulin-independent mechanism. 12 A genetic
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MATERIALS AND METHODS

Participant recruitment and sample collection
The samples analyzed in this study were a subset from a larger set collected for an ongoing genome-wide association study (GWAS) on obesity. Kuwaiti natives were randomly recruited under protocols approved by the scientific and ethics advisory boards at the Dasman Diabetes Institute. Most participants were patients enrolled with primary health centers and clinics at the institute. Written informed consent for the study was obtained from participants before blood samples were collected. Data were analyzed anonymously.
All participants completed standardized and validated questionnaires that collect self-reported information on medical conditions and family history of hypertension and diabetes. 14 The self-reported medical conditions were cross-checked with clinical records for participants enrolled as patients with clinics at our institute. Information on physical exercise and use of tobacco and alcohol was collected in the form of "yes" or "no" answers. Demographic data, body measurements, and vital signs were recorded by trained nurses who used standardized procedures. Three blood pressure readings were taken at the time of enrollment, and the mean of two or more readings that did not differ from one another by 5 mm HG was recorded. Blood samples were collected by trained nurses using standard protocols (see Supplementary Information) .
Using the genome-wide genotype data, we performed a series of sample quality checks that included genetic relatedness and mixed ancestry (see Supplementary  Information) . The set of GWAS samples that passed quality control steps was resampled (see Supplementary Information) to randomly choose 332 samples to form a case-control set for targeted sequencing and study hypertension.
Plasma leptin level measurements
Leptin levels were measured from plasma samples using the Human Leptin DuoSet enzyme-linked immunosorbent assay (ELISA) kit (DY398; R&D, Minneapolis, MN; see Supplementary Information).
Stepwise targeted sequencing of LEP, MC3R, and MC4R genes LEP and MC3R genes are coded on the forward strand and MC4R is coded on the reverse strand of genomic DNA. Fragments (Supplementary Table S1 ) encompassing the exons of these three genes and spanning into the flanking intronic regions were sequenced. The primers are as mentioned in Supplementary Table S2 . The fragments were sequenced using the Sanger sequencing method on an 3730xl DNA analyzer (Applied Biosystems, Foster City, CA, USA) as previously described. 15 Upon sequencing the exon fragments of LEP, MC3R, and MC4R in an initial set of 124 samples, it was seen that the MC4R variants occurred less frequently (<3%). More than 1,000 samples are required to demonstrate statistical significance of association with such rare variants (see Supplementary Information for power calculations). Since finding the role of rare variants is beyond the scope of this current study, we did not sequence MC4R fragments in additional samples. Instead, we sequenced LEP and MC3R gene fragments, which harbor variants at >5% frequency, in all 332 samples. We identified the gene variants by using the multiple sequence alignment method implemented in ClustalW 16 software (version 2.1).
Estimation of MC3R expression by quantitative reverse transcription-polymerase chain reaction analysis
Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to estimate the mRNA levels of MC3R. An RNeasy Mini Kit (Qiagen, Valencia, CA, USA) was used to extract the total RNA. The first strand of cDNA was synthesized using 1 µg of total RNA and a high-capacity cDNA reverse transcription kit (Invitrogen, Carlsbad, CA, USA). Next, 50 ng of cDNA and 5 pmol of both forward and reverse primers were used in each subsequent real-time PCR reaction in the presence of SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on the 7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA). All PCR reactions were performed in duplicate. The mRNA levels were normalized against the internal control glyceraldehyde-3-phosphate dehydrogenase (GADPH); the amounts of MC3R-mRNA relative to control were calculated using the ∆∆Ct method. 17 The primers used for the experiment are presented in Supplementary Table S3 .
Quality control and statistical analysis PLINK (version 1.07) was used to analyze genetic data. 18 We calculated minor allele frequency (MAF) and HardyWeinberg equilibrium (HWE) for all identified variants. Statistical association analyses with SBP, diastolic blood pressure (DBP), body mass index (BMI), waist circumference (WC), weight, and plasma leptin levels were performed using multiple linear regressions under the additive mode of inheritance. We adjusted for covariates such as age, gender, antihypertensive medication (AHM), and BMI when required. Multiple comparisons were corrected by generating empirical P (P emp ) values (using the max(T) permutation procedure available in PLINK) based on 10,000 permutations. Linkage disequilibrium (LD) between markers was calculated. Haplotype association tests were performed by constructing haplotypes using the standard E-M phasing and haplotype testing algorithm implemented in PLINK. Phenotype-genotype correlations were examined using the Pearson correlation test and comparisons of means were performed using the Student t test. All phenotype measurements are presented as mean ± standard error of the mean. In all cases of comparison, P ≤ 0.05 was considered to be statistically significant. We used the variant effect prediction tool 19 to distinguish between functionally neutral and deleterious amino acid changes based on SIFT 20 or PolyPhen 21 scores.
RESULTS
Study population and clinical characteristics
A total of 120 hypertensive patients and 212 nonhypertensive participants were included in the study. The participants were Kuwaiti natives recruited from Kuwait. Clinical characteristics of the participants from case and control datasets differ significantly, except for the parameters of smoking, alcohol consumption, physical exercise, and family history of hypertension (Table 1) .
Single marker association analysis
Multiple sequence alignment of exon fragments with reference gene sequences identified the following variants ( Figure 1) Table S4 ).
Comparison of minor allele frequencies (MAFs) of the identified variants across four major populations (African, American, Asian, and European) included in the 1000 Genomes Project 22 (Supplementary Table S5 ) reveals the following: the MAFs of the two MC3R variants in the Kuwaiti native population are almost twice those in European populations and the MC4R variants seen as rare in the Kuwaiti native population also occur at low frequencies in other populations. Statistical association tests on variants suggest that rs3746619 and rs3827103 are associated (P <0.05) with the quantitative trait of SBP in all three models of correction for covariates (namely, adjusting for age and gender; adjusting for age, gender, and AHM; and adjusting for age, gender, AHM, and BMI; Table 2 ). However, when P emp (corrections for multiple comparison) is considered, only rs3827103 is seen to be significantly associated with SBP at P emp = 0.01 in all three models. The MC3R variants rs3746619 and rs3827103 are found to be in moderate LD with each other (r 2 = 0.65). Haplotype association analysis (Table 3) indicates that the haplotype AA is significantly associated with SBP at P = 0.002 and P emp = 0.005 (β = 5.00) in all three models of correction for covariates. It was also observed that the CG haplotype is significantly associated with SBP (P = 0.02; P emp = 0.05) with protective effect (β = −3.2).
Tests for association of MC3R variants with DBP and obesity traits did not reveal any statistically significant association (data not shown). No variants of LEP were seen being associated with either hypertension or obesity traits.
Phenotype-genotype correlations: Plasma leptin levels, blood pressure levels, and obesity traits Analysis of how leptin levels correlate with SBP in individuals with GG, GA, and AA genotypes at rs3827103 ( Figure 2) and CC, CA, and AA at rs3746619 (Figure 3 ) reveals the following: GA polymorphism at rs3827103 or CA polymorphism at rs3746619 leads to positive correlation between leptin levels and SBP/DBP; GG at rs3827103 or CC at rs3746619 leads to the absence of correlation between leptin levels and SBP/DBP; AA genotype at either of the two variant positions leads to no correlation between leptin levels and SBP/DBP. Similar analysis on co-occurring polymorphisms (Table 4 ) at rs3746619 and rs3827103 indicates a positive correlation between leptin levels and SBP or DBP in individuals with CA-GA genotypes and no significant correlation in the case of CC-GG or AA-AA genotypes. Analysis of correlations between leptin levels and obesity traits (Table 4) indicates that irrespective of the polymorphisms seen at rs3827103 (GA or GG) and at rs3746619 (CA or CC) and irrespective of the co-occurring polymorphisms, the leptin levels are positively correlated with all the considered obesity traits (namely, weight, BMI, and WC).
Comparison of mean SBP values in individuals with GA vs. GG genotypes at rs3827103 or CA vs. CC genotypes at rs3746619 reveals a significant observation with the rs3827103 variant: the mean value of SBP in individuals with the rs3827103:GA genotype is significantly higher (127.18 ± 1.82) than that for those with the GG genotype (121.47 ± 0.96; P = 0.006). The CA vs. CC genotypes at Table S6 ).
Literature reports exist to suggest that obese individuals can have high leptin levels 4 and that Mc3r -/-mice can be hyperleptinemic. 23 However, we found no significant difference in leptin levels between individuals with GA vs. GG genotypes (4.41 ± 0.05 vs. 4.42 ± 0.03). This is probably because both groups showed similar BMI levels (32.98 ± 1.06 vs. 32.00 ± 0.52) and included a significant number of obese individuals (at 55% and 51%).
Functional validation of MC3R variants
In an attempt to understand how the observed variations at rs3746619 and rs3827103 influence expression of MC3R, we measured mRNA levels in 15 individuals. These individuals were chosen randomly to represent each of the five groups (CC-GG, CA-GA, AA-AA, CA-GG, and CC-GA) that represent different co-occurrences of genotypes at rs3746619 and rs3827103. The measured mRNA concentrations in each group and the phenotype characteristics are presented in Supplementary Table S7 . There is no particular bias in the phenotype characteristics of these individuals except that 11 of the 15 were females. The mean expression levels in the groups of CA-GA or CA-GG variant genotypes were significantly lower than that in the group of normal genotypes (CC-GG; P = 0.042 and P = 0.009, respectively). The CC-GA group also showed considerable downregulation (at 0.47) as compared with the normal genotype. In summary, the presence of either CA at rs3746619 and/or GA at rs3827103 could hamper expression of MC3R.
DISCUSSION
Single-marker association tests point to the missense variant rs3827103 [Val81Ile] in MC3R as being statistically associated with the quantitative trait of SBP. The haplotype that involves the rs3827103 and an N-terminus missense variant rs3746619 [Thr6Lys] (both are in linkage disequilibrium) is likewise associated with SBP. Expression of MC3R is downregulated in individuals who harbor alternate genotypes GA and AA against the reference GG genotype at rs3827103 or alternate genotypes CA and AA against the reference CC genotype at rs3746619 or in individuals who harbor co-occurrence of alternate genotypes against the reference GG-CC. In such MC3R-insufficient individuals, plasma leptin levels are positively correlated with SBP; the positive correlation is not seen in individuals who harbor normal genotypes. Leptin levels are positively correlated with obesity traits (namely, BMI, weight, and WC) irrespective of the genotypes at the two variant positions. The mean value of SBP in individuals with alternate GA genotypes at rs3827103 is significantly different from that in individuals with the reference GG genotype. The results lead to the following observations: while leptin levels are positively correlated with obesity traits in all individuals evaluated, a positive correlation with SBP/DBP is observed only in a subset of individuals who harbor alternate genotypes at the two variant positions in MC3R, and MC3R expression is downregulated in individuals with these alternate genotypes. Minor allele frequencies of the two MC3R variants in the Kuwaiti native population are almost twice those in European populations.
The Thr6 →Lys and the Val81→Ile variants that we identified as significantly associated with SBP in the Kuwaiti population have been discussed in the literature. Yako et al., 13 by considering black and colored students in a South African population, found that the MC3R variants show a negative effect on blood pressure and weight gain; however, they found this association to be primarily among colored students. Furthermore, certain variants in MC3R have also been implicated in monogenic forms of obesity, which are commonly associated with hypertension. 24 Our results reveal that interactions between leptin and MC3R might regulate blood pressure. The possibility of Table 4 . Correlations among obesity traits, systolic blood pressure, and plasma leptin levels in individuals with genotypes (GA or GG) at rs3827103, genotypes (CA or CC) at rs3746619, and with co-occurrence of genotypes (CC-GG, CA-GA and AA-AA) at rs3746619-rs3827103 9 Also, studies involving animal models have proposed that either MC3R or MC4R in conjunction with leptin can regulate obesity and hypertension. 7, 12 Further, Feng et al. 25 demonstrated that rs3746619 and rs3827103 mutations lead to reduced expression of MC3R, and they hypothesized that the reduced expression is probably a predisposing factor for obesity in children. Based on our findings, we report that reduced MC3R expression (in individuals who harbor alternate genotypes) might be a predisposing factor for hypertension. As variants in MC4R are found to be rare, we can conclude that MC3R alone (through interactions with leptin) take part in the elevation of blood pressure in the majority of the population. Earlier studies showed that MC3R exerts a tonic excitatory effect on SNA and blood pressure via the cAMP-protein kinase A pathway 8 by leptininduced STAT3 signaling. 3 This raises the possibility that downregulation of MC3R expression in conjunction with leptin levels mediates hypertension by disrupting the cAMP pathway.
The cohort of Kuwaiti natives included participants with other metabolic diseases that are highly prevalent in Kuwait. 26 Therefore, comorbidity might represent a confounding factor and be considered as a potential limitation of this study.
The rs3827103 variant and its haplotype with rs3746619 in MC3R are seen to be associated with SBP. Individuals who harbor these variants exhibit a positive correlation between leptin levels and SBP, and such individuals also exhibit downregulation of MC3R expression. Notable observations from the literature on interactions that the leptin and melanocortin system has with SNA in regulating blood pressure (as demonstrated in animal models) are as follows: leptin increases renal SNA through activation of hypothalamic melanocortin receptors, 6 an increase in SNA is believed to increase blood pressure in obesity, 7 and activation or deactivation of MC3R/MC4R can modulate the levels of sympathetic outflow. 8 In light of these literature reports and our findings, it is possible that MC3R variants in association with plasma leptin levels are involved in the regulation of blood pressure in humans.
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